Motrin and Carbatrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Motrin (ibuprofen) and Carbatrol (carbamazepine). Common drug interactions include abdominal pain upper among females and nephritis among males.

The phase IV clinical study analyzes what interactions people have when they take Motrin and Carbatrol. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Motrin?

Motrin has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 38,332 Motrin users. Check the latest studies of Motrin.

What is Carbatrol?

Carbatrol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 1,979 Carbatrol users. Check the latest studies of Carbatrol.



On Aug, 03, 2026

15 people who take Motrin and Carbatrol together, and have interactions are studied.

Motrin and Carbatrol drug interactions.

What are the common drug interactions of Motrin and Carbatrol, by gender? *:

female:

  1. Abdominal pain upper
  2. Dizziness
  3. Eating disorder
  4. Insomnia (sleeplessness)
  5. Abdominal discomfort
  6. Asthenia (weakness)
  7. Asthma
  8. Brain damage
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

male:

  1. Nephritis (inflammation of the nephrons in the kidneys)
  2. Blood urea increased
  3. Pneumonia
  4. Anaemia (lack of blood)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Blood alkaline phosphatase increased
  7. Blood chloride increased
  8. Blood creatinine increased
  9. Blood immunoglobulin g decreased
  10. Blood phosphorus increased

What are the common drug interactions of Motrin and Carbatrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Asthma
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Circulatory collapse
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Loss of consciousness
  7. Pain in extremity
  8. Pulmonary embolism (blockage of the main artery of the lung)

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Anticonvulsant drug level decreased
  4. Asthenia (weakness)
  5. Brain damage
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Dizziness
  10. Drug ineffective

40-49:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Blood alkaline phosphatase increased
  3. Blood chloride increased
  4. Blood phosphorus increased
  5. Blood potassium increased
  6. Blood urea increased
  7. Cerebral atrophy (decrement in size of brain)
  8. Chest pain
  9. Cough
  10. Dizziness

60+:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Nephritis (inflammation of the nephrons in the kidneys)
  3. Anaemia (lack of blood)
  4. Blood creatinine increased
  5. Blood immunoglobulin g decreased
  6. Blood urea increased
  7. Csf lactate dehydrogenase increased
  8. Csf lymphocyte count increased
  9. Csf protein increased
  10. Csf white blood cell count increased

What are the existing conditions these people have? *

  1. Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 5 people, 33.33%
  2. Nausea (feeling of having an urge to vomit): 4 people, 26.67%
  3. Depression: 4 people, 26.67%
  4. Stress And Anxiety: 2 people, 13.33%
  5. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 13.33%
  6. Pneumonia: 2 people, 13.33%
  7. Psychotic Disorder: 1 person, 6.67%
  8. Nerve Injury: 1 person, 6.67%
  9. Migraine (headache): 1 person, 6.67%
  10. Jaw Disorder (jaw disease): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Motrin and Carbatrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Motrin and Carbatrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Motrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carbatrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Motrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbatrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and carbamazepine (the active ingredients of Motrin and Carbatrol, respectively), and Motrin and Carbatrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: